Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Deferred Income Tax Liabilities, Net

2.4 / 5 stars · 56/117 Roast Me

Lantheus Holdings, Inc. Deferred Income Tax Liabilities, Net

Lantheus Holdings, Inc. (LNTH) had Deferred Income Tax Liabilities, Net of $54.06 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-06

  • 2026-06-30: Deferred Income Tax Liabilities, Net $54.06M.
  • 2026-03-31: Deferred Income Tax Liabilities, Net $53.51M.
  • 2025-12-31: Deferred Income Tax Liabilities, Net $54.25M.
  • 2025-09-30: Deferred Income Tax Liabilities, Net $55.08M.
Period endDeferred Income Tax Liabilities, Net
2026-06-30$54.06M
10-Q · filed 2026-08-06
2026-03-31$53.51M
10-Q · filed 2026-05-07
2025-12-31$54.25M
10-Q · filed 2026-08-06
2025-09-30$55.08M
10-Q · filed 2025-11-06
2024-12-31$0.00
10-K · filed 2026-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B